Graphene 3D Lab Inc(British Columbia)
Change company Symbol lookup
Select an option...
GPHBF Graphene 3D Lab Inc(British Columbia)
ITRI Itron Inc
LTTTX MFS Lifetime 2025 Fund Class R3
HLI Houlihan Lokey Inc
KICK Master Glazier's Karate International Inc
VIRT Virtu Financial Inc
FB Facebook Inc
ED Consolidated Edison Inc
CLS Celestica Inc
HNHAF Hon Hai Precision Industry Co Ltd
Go

Materials : Chemicals | Small Cap Growth
Company profile

Graphene 3D Lab Inc. is engaged in the business of developing, manufacturing and marketing polymer nanocomposite graphene-based materials. The Company is also engaged in the development, manufacturing and marketing of graphene and other two-dimensional (2D) crystals, as well as composites based on these nanomaterials. These materials have a spectrum of commercial, research and military applications. The three-dimensional (3D) printing division offers a portfolio of specialty fused filament fabrication filaments. Its Industrial Materials Division develops graphene-infused polymers targeted for automotive, robotics, drone, aerospace and military industries. The Company, through Graphene Laboratories Inc., is engaged in manufacturing and retailing of graphene and advanced materials. It markets its materials to various industries, including the aerospace, manufacturers of medical prosthetics, as well as the various types materials for 3D printing, such as fused filament fabrication.

Closing Price
$0.0975
Day's Change
0.004 (4.28%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.101
Day's Low
0.0876
Volume
(Light)
Volume:
279,281

10-day average volume:
605,165
279,281

Lawsuits Filed Against BTU, FAF and BIIB - Jakubowitz Law Pursues Shareholders Claims

6:21 am ET November 25, 2020 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / November 25, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Peabody Energy Corporation (NYSE:BTU)

CONTACT JAKUBOWITZ ABOUT BTU:https://claimyourloss.com/securities/peabody-energy-corporation-loss-submission-form/?id=11212&from=1

Class Period : April 3, 2017 - October 28, 2019

Lead Plaintiff Deadline : November 27, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) the Company had failed to implement adequate safety controls at the North Goonyella mine to prevent the risk of a spontaneous combustion event; (b) the Company failed to follow its own safety procedures; (c) as a result, the North Goonyella mine was at a heightened risk of shutdown; (d) the Company's low-cost plan to restart operations at the mine posed unreasonable safety and environmental risks; (e) The Australian body responsible for ensuring acceptable health and safety standards, the Queensland Mines Inspectorate, would likely mandate a safer, cost-prohibitive approach; and (f) as a result, there would be major delays in reopening the North Goonyella mine and restarting coal production.

First American Financial Corp. (NYSE:FAF)

CONTACT JAKUBOWITZ ABOUT FAF:https://claimyourloss.com/securities/first-american-financial-corp-loss-submission-form/?id=11212&from=1

Class Period : February 17, 2017 - October 22, 2020

Lead Plaintiff Deadline : December 24, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company failed to implement basic security standards to protect its customers' sensitive personal information and data; (2) the Company faced a heightened risk of cybersecurity failure due to its automation and efficiency initiatives; and (3) as a result, Defendants' public statements were materially false and misleading at all relevant times.

Biogen Inc. (NASDAQ:BIIB)

CONTACT JAKUBOWITZ ABOUT BIIB:https://claimyourloss.com/securities/biogen-inc-loss-submission-form/?id=11212&from=1

Class Period : October 22, 2019 - November 6, 2019

Lead Plaintiff Deadline : January 12, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the larger dataset did not provide necessary data regarding aducanumab's effectiveness; (2) the EMERGE study did not and would not provide necessary data regarding the effectiveness of aducanumab, Biogen's investigational human monoclonal antibody studied for the treatment of early Alzheimer's disease; (3) the PRIME study did not and would not provide necessary data regarding aducanumab's effectiveness; (4) the data provided by the Company to the U.S. Food and Drug Administration's Peripheral and Central Nervous System Drugs Advisory Committee did not support finding efficacy of aducanumab; and (5) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:JAKUBOWITZ LAW1140 Avenue of the Americas9th FloorNew York, New York 10036T: (212) 867-4490F: (212) 537-5887

SOURCE: Jakubowitz Law

View source version on accesswire.com: https://www.accesswire.com/618342/Lawsuits-Filed-Against-BTU-FAF-and-BIIB--Jakubowitz-Law-Pursues-Shareholders-Claims

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.